drugset / Trial / NCT00520260
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Phase 4
Completed
42 enrolled
Florida Eye Microsurgical Institute
Bausch & Lomb Incorporated · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare bromfenac 0.09% and ketorolac 0.4% when used concomitantly with cyclosporine ophthalmic emulsion 0.05% in improving patient comfort during the induction phase of treatment for chronic dry eye disease
Timeline
- Start
- 2007-08
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bromfenac | Other / unclassified | 0.09 % | — |
| Comparator | Ketorolac | Other / unclassified | 0.4 % | — |